We are live on ! Find out more
BMED icon

iShares Health Innovation Active ETF

4 hedge funds and large institutions have $2.14M invested in iShares Health Innovation Active ETF in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.49% less ownership

Funds ownership: 30.59% → 30.11% (-0.49%)

13% less capital inflows, than outflows

Capital inflows: $672K | Capital outflows: $776K

20% less funds holding

Funds holding: 5 → 4 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$644K
2
Jane Street
Jane Street
New York
+$27.6K

Top Sellers

Rank Fund Capital Flow
1
Flow Traders U.S.
Flow Traders U.S.
New York
-$763K
2
UBS Group
UBS Group
Switzerland
-$13.5K

BMED Hedge Fund Activity: Q2 2022 in Review

4 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in iShares Health Innovation Active ETF (BMED) for Q2 2022, worth a combined $2.14M — down 14% from $2.48M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BMED and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, adding an estimated $644K. The largest seller was Flow Traders U.S., exiting entirely with an estimated $763K sold.

  • 4 institutional investors held iShares Health Innovation Active ETF (BMED) as of Q2 2022, down from 5 in Q1 2022.
  • Funds reported $2.14M of iShares Health Innovation Active ETF stock for Q2 2022, down 14% quarter-over-quarter.
  • 0 funds opened new iShares Health Innovation Active ETF positions in Q2 2022 and 1 closed out, a net change of -1 holder.
  • The largest iShares Health Innovation Active ETF buyer in Q2 2022 was Citadel Advisors, an estimated $644K added.
  • The largest iShares Health Innovation Active ETF seller in Q2 2022 was Flow Traders U.S., an estimated $763K sold.

Based on aggregated 13F filings for Q2 2022.